Prediction: Stocks That Will Outperform Summit in One Year
Spotlighting two strong growth names that could exceed Summit Therapeutics in a year. Learn the catalysts, risks, and...
This article helps you decide between taxable and tax-exempt bond funds in retirement, outlining allocation strategies and tax considerations.
25,011 articlesSpotlighting two strong growth names that could exceed Summit Therapeutics in a year. Learn the catalysts, risks, and...
Wedbush raises Apple’s price target to $400, arguing a coming AI shift could position Apple as the main AI distributi...
Two AI bets with very different risk profiles surfaced as Microsoft and Palantir reported earnings. Microsoft leans o...
Planet Fitness posted a robust surge in revenue, but a large investor trimmed a substantial stake. This article break...
A rival’s blowout earnings stirred optimism across hardware names. This piece breaks down why super micro computer st...
Ciena's 2026 earnings outlook blends hardware demand with software growth. This guide breaks down the drivers, risks,...
Apple is accelerating AI across its ecosystem. This article breaks down the two big profit engines, what it means for...
The first half of 2026 delivered a housing market that steadied into a new normal. Here are the five lessons that def...
A notable drop in this homebuilder's average selling price points to easier affordability for buyers. As demand shift...
The data center build-out accelerating wave is reshaping where investors place bets. Beyond chips, three infrastructu...
If you had $1,000 to put into a single stock this July, MercadoLibre could stand out for growth potential and a robus...
A landmark portfolio reshuffle puts Alphabet ahead of Berkshire's long-time Coca-Cola cornerstone. This analysis expl...